Back to search
FDAFDA · Food and drugs·Recall number Z-0678-2025

Hybrid Recon software on Hermes Medical Imaging Suite version 6.1 Hybrid Recon software versions affected are 4.0.0x and 5.0.0

Published December 18, 2024 · Recall initiated: October 31, 2024

Summary

FDA records medical device Class II recall Z-0678-2025, published December 18, 2024 and initiated October 31, 2024. Recalling firm: Hermes Medical Solutions AB; Status: Ongoing; Reported quantity: 778 systems; Lot: Hermes Medical Imaging System version 6.1 with Hybrid Recon version 4.0.x UDI-DI code: 00859873006158 Serial Numbers: Pending Hybrid Recon version 5.0.0 UDI code: (01)00859873006196(8012)005000000 Serial Numbers: Pending. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due a potential software/configuration issue that may result is incorrect alignment during reconstructing a SPECT/CT study.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hermes Medical Solutions AB
Distributor
U.S.: CA, CT, FL, HI, KY, MA, MD, MO, NJ. NY, OH, TN, TX, VA, and WA O.U.S.: Germany, and United Kingdoms
Lot
Hermes Medical Imaging System version 6.1 with Hybrid Recon version 4.0.x UDI-DI code: 00859873006158 Serial Numbers: Pending Hybrid Recon version 5.0.0 UDI code: (01)00859873006196(8012)005000000 Serial Numbers: Pending
Risk classification
Class II
Area (FDA)
device
Country
Sweden

Related recalls

Questions about this recall

Was Hybrid Recon software on Hermes Medical Imaging Suite version 6.1 Hybrid Recon software versions affected are 4.0.0x and 5.0.0 recalled?

Yes. FDA published recall Z-0678-2025 on December 18, 2024. Reported hazard: Due a potential software/configuration issue that may result is incorrect alignment during reconstructing a SPECT/CT study.

What should I do if I have this product?

Voluntary: Firm initiated · Letter